Comvax Vaccine and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Comvax Vaccine and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine
Brand name:
Synonyms: Haemophilus b conjugate and hepatitis b vaccine (Intramuscular)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Comvax Vaccine-Insulin degludec
- Comvax Vaccine-Insulin Degludec (U-100) Prefilled Pens
- Comvax Vaccine-Insulin Degludec (U-100) Vials
- Comvax Vaccine-Insulin Degludec (U-200) Prefilled Pens
- Comvax Vaccine-Insulin degludec and liraglutide
- Comvax Vaccine-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Conal
- Insulin aspart, recombinant Subcutaneous-Concept DHA
- Insulin aspart, recombinant Subcutaneous-Concept OB
- Insulin aspart, recombinant Subcutaneous-Concept OB Capsules
- Insulin aspart, recombinant Subcutaneous-Concerta
- Insulin aspart, recombinant Subcutaneous-Conestat alfa